Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma.
about
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic CeMaintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.Exploring Big Data in Hematological Malignancies: Challenges and Opportunities.Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease responseLimiting early mortality: Do's and don'ts in the management of patients with newly diagnosed multiple myeloma.Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experience.Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era.Comparison of conditioning regimen toxicities among autologous stem cell transplantation eligible multiple myeloma patients: High-dose melphalan versus high-dose melphalan and bortezomib.Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group.Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.
P2860
Q26782868-9551AADD-F647-42D8-9A67-86F998D30AD0Q30275382-91E53808-806B-4253-B112-EC879A8E660CQ31095966-3F549573-F02C-466F-9608-71A1F8221BC6Q37593761-67D2F939-6830-45F8-8555-D171E4A6CB78Q38555091-386610A3-1E47-4B17-98C7-2C3B678322DBQ38780843-67488C99-A2C2-418A-A1CA-7D8FABDEB619Q38843140-32E9F37A-5814-442A-A331-671466C41A95Q41091821-3C46FD00-1C9C-4B9B-86B5-F3B0B8368BF9Q47238436-C56BAD8A-C09F-4304-BEEC-1E2B83BBEF7AQ48848774-7B32C0AB-03F7-4053-BB51-BFA674397146Q52860687-CD936061-8127-4DBF-86EC-72C2BE4DB871
P2860
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Impact of pretransplant therap ...... antation for multiple myeloma.
@ast
Impact of pretransplant therap ...... antation for multiple myeloma.
@en
type
label
Impact of pretransplant therap ...... antation for multiple myeloma.
@ast
Impact of pretransplant therap ...... antation for multiple myeloma.
@en
prefLabel
Impact of pretransplant therap ...... antation for multiple myeloma.
@ast
Impact of pretransplant therap ...... antation for multiple myeloma.
@en
P2093
P2860
P50
P1476
Impact of pretransplant therap ...... antation for multiple myeloma.
@en
P2093
Baldeep Wirk
César O Freytes
Dan T Vogl
Daniel J Landsburg
Jennifer M Bird
Jiaxing Huang
Manish Sharma
Mei-Jie Zhang
Reinhold Munker
P2860
P304
P356
10.1016/J.BBMT.2014.10.023
P577
2014-11-01T00:00:00Z